Literature DB >> 24788569

Clinical and pathological features of patients with nemaline myopathy.

Xi Yin1, Chuan Qiang Pu1, Qian Wang1, Jie Xiao Liu1, Yan Ling Mao1.   

Abstract

Nemaline myopathy (NM) is a rare congenital myopathy of great heterogeneity, characterized by the presence of rods in the cytoplasm of muscle fibers. This study aimed to summarize and analyze retrospectively the clinicopathological features of 28 patients with NM. Among the 28 patients, 15 were classified as of the typical congenital type, manifested as lower- or four-limb weakness as the first symptom and slowly progressive course. Six patients were classified as of childhood onset type, with lower-limb weakness and progressive course. Seven patients were classified as of the adult onset type, with rapidly progressive course and obvious muscle atrophy. Patient's 1, 16 and 23 had rapid clinical progression. On follow up, the three patients showed respiratory failure. Limb weakness in all patients was proximal‑dominant. Hypotonia was observed in most patients. High arched feet were also observed as dysmorfic features. In all patients, the creatine kinase (CK) level was normal or mildly elevated, and electromyography revealed myogenic changes. Nemaline bodies were observed under a light microscope in more than half of the patients' muscle fibers, and especially in type I fibers. All patients showed fiber type I predominance and atrophy. Modified Gömöri trichrome staining showed characteristic purple‑colored rods. Muscle electron microscopy revealed the presence of high electron‑dense nemaline bodies around the nucleus, and of a disorganized myofibrillar apparatus, with broken myofilaments and irregular myofibrils and Z lines. The 28 patients with NM shared a number of clinical features, such as proximal limb weakness, reduced deep tendon reflex and dysmorfic features. Differences were also observed between the three types of patients, with regards to course progression, disease severity and respiratory failure. In conclusion, patients with NM showed great clinical heterogeneity. The diagnosis of NM was mainly based on the muscle biopsy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788569     DOI: 10.3892/mmr.2014.2184

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  The KLHL40 c.1516A>C is a Chinese-specific founder mutation causing nemaline myopathy 8: Report of six patients with pre- and postnatal phenotypes.

Authors:  Kit San Yeung; Florrie N Y Yu; Cheuk Wing Fung; Sheila Wong; Hencher H C Lee; Sharon T H Fung; Genevieve P G Fung; Kwok Yin Leung; Wai Hang Chung; Yun Ting Lee; Vivian K S Ng; Mullin H C Yu; Jasmine L F Fung; Mandy H Y Tsang; Kelvin Y K Chan; Sophelia H S Chan; Anita S Y Kan; Brian H Y Chung
Journal:  Mol Genet Genomic Med       Date:  2020-04-30       Impact factor: 2.183

2.  A Cross-Sectional Study of Nemaline Myopathy.

Authors:  Kimberly Amburgey; Meryl Acker; Samia Saeed; Reshma Amin; Alan H Beggs; Carsten G Bönnemann; Michael Brudno; Andrei Constantinescu; Jahannaz Dastgir; Mamadou Diallo; Casie A Genetti; Michael Glueck; Stacy Hewson; Courtney Hum; Minal S Jain; Michael W Lawlor; Oscar H Meyer; Leslie Nelson; Nicole Sultanum; Faiza Syed; Tuyen Tran; Ching H Wang; James J Dowling
Journal:  Neurology       Date:  2021-01-04       Impact factor: 9.910

3.  Clinico-pathological features and mutational spectrum of 16 nemaline myopathy patients from a Chinese neuromuscular center.

Authors:  Xi Yin; Chuanqiang Pu; Zhenfu Wang; Ke Li; HuiFang Wang
Journal:  Acta Neurol Belg       Date:  2021-03-19       Impact factor: 2.471

4.  Beyond the "Jewish panel": the importance of offering expanded carrier screening to the Ashkenazi Jewish population.

Authors:  Shelley Dolitsky; Anjali Mitra; Shama Khan; Elena Ashkinadze; Mark V Sauer
Journal:  F S Rep       Date:  2020-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.